Publication | Open Access
Risk of tuberculosis, serious infection and lymphoma with disease‐modifying biologic drugs in rheumatoid arthritis patients in Taiwan
39
Citations
32
References
2014
Year
There was a higher risk for specified infections and lymphoma with bDMARD versus tDMARD and adalimumab versus etanercept.
| Year | Citations | |
|---|---|---|
Page 1
Page 1